• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Cancer Genomics for the Clinician

Cancer Genomics for the Clinician

9780826168672
374,22 zł
336,80 zł Zniżka 37,42 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 336,80 zł
Ilość
Produkt niedostępny
Chwilowy brak

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Cancer Genomics for the Clinician is a practical guide to cancer genomics and its application to cancer diagnosis and care. The book begins with a brief overview of the various types of genetic alterations that are encountered in cancer, followed by accessible and applicable information on next generation sequencing technology and bioinformatics, tumor heterogeneity, whole genome, exome and transcriptome sequencing, epigenomics, and data analysis and interpretation. Each chapter provides essential explanations of concepts, terminology, and methods. Also included are tips for interpreting and analyzing molecular data, as well as a discussion of molecular predictors for targeted therapies covering hematologic malignancies and solid tumors. The final chapter explains the use of FDA-approved genomic-based targeted therapies for breast cancer, lung cancer, sarcomas, gastrointestinal cancers, urologic cancers, head and neck cancer, thyroid cancer, and many more. Assembled in an accessible format specifically designed for the non-expert, this book provides the clinical oncologist, early career practitioner, and trainee with an essential understanding of the molecular and genetic basis of cancer and the clinical aspects that have led to advancements in diagnosis and treatment. With this resource, physicians and trainees will increase their breadth of knowledge and be better equipped to educate patients and families who want to know more about their genetic predispositions to cancer and the targeted therapies that could be considered and prescribed. Key Features:: Describes how cancer genomics and next generation sequencing informs cancer screening, risk factors, therapeutic options, and clinical management across cancer types Explains what mutations are, what tests are needed, and how to interpret the results Provides information on FDA-approved targeted therapies that are being used in the clinic Covers different sequencing platforms and technologies and how they perform in research settings Includes access to the fully-searchable downloadable digital version
Szczegóły produktu
Eurospan
67824
9780826168672
9780826168672

Opis

Rok wydania
2019
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
300
Wymiary (mm)
152.00 x 229.00
  • Chapter One:: Introduction to Cancer Genomics Deepali Jain, Brett Herzog, and Leonard B. Maggi, Jr. Chapter Two:: Tumor Mutational Profiling by Next Generation Sequencing Samantha N. McNulty, Latisha Love-Gregory, and Jonathan W. Heusel Chapter Three:: Bioinformatics:: What a Clinician Should Know Irena Lanc and Arpad Danos Chapter Four:: Tumor Heterogeneity Alex H. Wagner, Kilannin Krysiak, Katie M. Campbell, and Erica K. Barnell Chapter Five:: Epigenetics Alterations in Cancer Erica C. Pehrsson, Hyo Sik Jang, and Ting Wang Chapter Six:: Cell-Free DNA in Cancer Diagnosis and Follow-Up Bruna Pellini Ferreira and Daniel Morgensztern Chapter Seven:: Optimizing Targeted Therapies Using Next Generation Sequencing Brett Herzog and Saiama N. Waqar
Komentarze (0)